Amerise Biosciences Ltd (AMERISE) is currently trading at 0.86 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Amerise Biosciences Limited (formerly Amstar Laminates and Amardeep Industries) is a small, listed Indian company that historically manufactured construction and agricultural equipment and later engaged in commodity trading, including castor seeds; it rebranded to a biosciences name in 2021 but reported no substantive operating activity during the 2024-25 year due to a financial crisis. The latest unaudited results for quarter ended September 30, 2025 show zero revenue from operations and other income of Rs.6.75 lakhs for the quarter, producing a net loss of Rs.4.23 lakhs for the quarter and Rs.5.04 lakhs for the six-month period, with basic EPS around negative Re.0.01 and minimal operating cash generation. Balance sheet composition is non-operational: non-current assets are dominated by investments of Rs.376.97 lakhs and long-term loans of Rs.459.49 lakhs, while current assets are negligible (cash Rs.2.38 lakhs). Other current liabilities stand at Rs.305.50 lakhs and other equity is negative about Rs.127.75 lakhs, indicating material balance-sheet stress and limited liquidity. Corporate actions in the filing were limited to the board approval of the financial results and a limited review by statutory auditors, with no disclosed strategic transactions, capital raise, asset sale, or turnaround plan; management acknowledged inactivity in 2024-25 but provided no roadmap for resumption. Cash flow statement shows negative operating cash flow for the period and net investing inflows driven by changes in long-term loans; this implies movement in balance-sheet financing rather than operating recovery, leaving the company dependent on asset monetisation or fresh capital to address liabilities and restart operations.

Over the past 52 weeks, Amerise Biosciences Ltd has traded between a low of ₹0.50 and a high of ₹1.03. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Amerise Biosciences Ltd has a market capitalization of approximately 5.48. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Amerise Biosciences Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -78.29 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 5.48 Cr, Amerise Biosciences Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Amerise Biosciences Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Amerise Biosciences Ltd is -78.29. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Snehjeev Ventures and its persons acting in concert raised their aggregate holding to 9.02% in Amerise Biosciences. The threshold crossing required a disclosure under Regulation 29(2) of the SEBI SAST Regulations, 2011.